The new front line treatment for malignant pleural mesothelioma?
作者信息
Steele J P C
出版信息
Thorax. 2003 Feb;58(2):96-7. doi: 10.1136/thorax.58.2.96.
Abstract
摘要
相似文献
1
The new front line treatment for malignant pleural mesothelioma?
Thorax. 2003 Feb;58(2):96-7. doi: 10.1136/thorax.58.2.96.
2
Standard therapy for the treatment of malignant pleural mesothelioma.
Lung Cancer. 2005 Oct;50 Suppl 1:S23-4. doi: 10.1016/s0169-5002(05)81557-0.
3
Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care?
J Clin Oncol. 2003 Jul 15;21(14):2629-30. doi: 10.1200/JCO.2003.02.043.
4
[Malignant pleural mesothelioma: further options].
Arch Bronconeumol. 2005 Dec;41(12):703. doi: 10.1016/s1579-2129(06)60339-x.
5
Pemetrexed combination improves mesothelioma survival.
Lancet Oncol. 2005 Aug;6(8):548. doi: 10.1016/s1470-2045(05)70268-0.
6
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma.
Ann Oncol. 2005 Jun;16(6):923-7. doi: 10.1093/annonc/mdi187. Epub 2005 Apr 11.
7
Pemetrexed alone and in combination with platinum compounds in the management of malignant mesothelioma.
Clin Lung Cancer. 2004 Apr;5 Suppl 2:S56-60. doi: 10.3816/clc.2004.s.004.
8
Malignant mesothelioma.
N Engl J Med. 2006 Jan 19;354(3):305-7; author reply 305-7.
9
Pemetrexed-cisplatin combination in mesothelioma.
Expert Rev Anticancer Ther. 2005 Apr;5(2):231-7. doi: 10.1586/14737140.5.2.231.
10
Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program.
Lung Cancer. 2007 Feb;55(2):187-94. doi: 10.1016/j.lungcan.2006.09.023. Epub 2006 Nov 7.
引用本文的文献
1
Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma.
Ther Clin Risk Manag. 2008 Feb;4(1):205-11. doi: 10.2147/tcrm.s1603.
2
Management options for malignant pleural mesothelioma: clinical and cost considerations.
Drugs. 2007;67(8):1149-65. doi: 10.2165/00003495-200767080-00005.
3
New therapeutic options for mesothelioma.
Curr Oncol Rep. 2005 Jul;7(4):260-5. doi: 10.1007/s11912-005-0048-3.
4
BTS randomised feasibility study of active symptom control with or without chemotherapy in malignant pleural mesothelioma: ISRCTN 54469112.
Thorax. 2004 Feb;59(2):144-8. doi: 10.1136/thorax.2003.009290.
Zotero 插件